Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $107.5900 (-0.92%) ($107.2000 - $108.9100) on Thu. Aug. 18, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.13% (three month average) | RSI | 15 | Latest Price | $107.5900(-0.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.3% a day on average for past five trading days. | Weekly Trend | LGND declines -9.1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(52%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -1.065% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) IPO(-4%) GDXJ(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.065% (StdDev 2.13%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
1 - 5 Day Possible Target | $97.17(-9.68%) | Resistance Level | $123.47 | 5 Day Moving Average | $110.9(-2.98%) | 10 Day Moving Average | $113.64(-5.32%) | 20 Day Moving Average | $123.47(-12.86%) | To recent high | -22.3% | To recent low | 0% | Market Cap | $1.729b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |